Bevacizumab 400Mg

Bevacizumab 400Mg

Product Details:


Product Description

Bevacizumab 400Mg belongs to drug class of angiogenesis inhibitors and works by inhibiting vascular endothelial growth factor A. This activity of bevacizumab slows down growth of new blood vessels. It is indicated for treatment of certain types of cancers including renal cell carcinoma & glioblastoma. This intravenous injection also has got approval for treating age-related macular degeneration. It shows 100% of bioavailability via IV route with average elimination half life of about 20 days. Bevacizumab 400Mg is humanized recombinant monoclonal antibody which assures targeted mode of action with good survival rate.


* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.

Back to top
NEXT GEN BIOTECH All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.